Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 309 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms November 15, 2022 FDA Approves Pembrolizumab with Chemotherapy for HER2-negative Gastric or Gastro-Oesophageal Junction... December 14, 2023 Woman Creates Non-Toxic Nail Polish Brand After Her Mom’s Breast Cancer... November 20, 2020 How I Coped With My Own Cancer Diagnoses As an Oncologist October 13, 2022 Load more HOT NEWS Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling... FDA Approves HPV Tests That Allow for Self-Collection in a Health... Many Patients with NSCLC Show Targetable Alterations in the PI3K Pathway Modest Effectiveness of Screening Colonoscopy for the Prevention of Colorectal Cancer...
